These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26352540)

  • 1. State-of-the-art of bone marrow imaging in multiple myeloma.
    Martí-Bonmatí L; Ramirez-Fuentes C; Alberich-Bayarri Á; Ruiz-Llorca C
    Curr Opin Oncol; 2015 Nov; 27(6):540-50. PubMed ID: 26352540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Recent Results Cancer Res; 2011; 183():133-47. PubMed ID: 21509684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced multiple myeloma with negative bone marrow biopsy and positive soft tissue lesions in the (18)F-FDG PET/CT scan.
    Ceneli O; Haznedar R
    Hell J Nucl Med; 2008; 11(1):56-7. PubMed ID: 18392234
    [No Abstract]   [Full Text] [Related]  

  • 8. State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.
    Mesguich C; Fardanesh R; Tanenbaum L; Chari A; Jagannath S; Kostakoglu L
    Eur J Radiol; 2014 Dec; 83(12):2203-2223. PubMed ID: 25308249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern imaging of multiple myeloma.
    Seppanen M
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvement.
    Machida H; Shinohara T; Hino H; Yoshida M; Hatakeyama N; Okano Y; Inayama M; Hosokawa E; Abe S; Naruse K; Iwahara Y; Ogushi F
    Intern Med; 2011; 50(14):1483-7. PubMed ID: 21757834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
    In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
    Lütje S; de Rooy JW; Croockewit S; Koedam E; Oyen WJ; Raymakers RA
    Ann Hematol; 2009 Dec; 88(12):1161-8. PubMed ID: 19763570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA; Nguyen BD
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET in the evaluation of myeloma in 2012.
    Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
    Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.
    Hanrahan CJ; Christensen CR; Crim JR
    Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    J Comput Assist Tomogr; 2007; 31(3):342-7. PubMed ID: 17538276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of FDG PET in the assessment of patients with multiple myeloma.
    Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
    AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.